| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 30.909 | 34.154 | 47.215 | 33.918 | 35.912 | 37.362 | 44.511 | 34.622 | 21.042 | 13.174 |
| Total Income - EUR | 30.909 | 34.154 | 48.988 | 34.498 | 35.912 | 38.189 | 44.511 | 35.433 | 21.042 | 13.174 |
| Total Expenses - EUR | 31.751 | 17.634 | 25.160 | 26.905 | 30.282 | 31.947 | 31.017 | 43.315 | 38.514 | 41.200 |
| Gross Profit/Loss - EUR | -842 | 16.520 | 23.829 | 7.593 | 5.631 | 6.243 | 13.494 | -7.882 | -17.473 | -28.026 |
| Net Profit/Loss - EUR | -1.769 | 16.179 | 23.357 | 7.254 | 5.272 | 5.861 | 13.058 | -8.184 | -17.672 | -28.158 |
| Employees | 2 | 2 | 3 | 3 | 3 | 2 | 2 | 2 | 3 | 3 |
Check the financial reports for the company - Firamed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 30.857 | 25.023 | 19.372 | 28.864 | 19.385 | 6.275 | 2.085 | 0 |
| Current Assets | 8.991 | 54 | 2.640 | 11.198 | 18.408 | 25.465 | 33.720 | 32.017 | 17.330 | 37 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 501 | 0 | 0 | 0 |
| Receivables | 8.939 | 0 | 2.384 | 10.049 | 12.323 | 15.756 | 11.022 | 9.380 | 7.866 | 0 |
| Cash | 52 | 54 | 257 | 1.150 | 6.085 | 9.709 | 22.198 | 22.636 | 9.464 | 37 |
| Shareholders Funds | -33.456 | -16.935 | 6.708 | 13.839 | 18.843 | 24.347 | 36.865 | 28.796 | 11.036 | -17.183 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 42.447 | 16.990 | 26.790 | 22.382 | 18.937 | 29.982 | 16.240 | 9.496 | 8.379 | 17.220 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6831 - 6831" | |||||||||
| CAEN Financial Year |
6831
|
|||||||||
Comments - Firamed S.r.l.